Camurus (OTC:CAMRF) Stock, Quote.Headers.trade-ideas

Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AACS

AAON

AAUKF

ACDSF

ACGL

ACIA

ACLS

ADBE

ADSK

ADYYF

AFFY

AFGC

AIQUY

AJMPF

AKAM

ALCO

ALFVY

ALLE

ALLT

AMADY

AMAT

AMBC

AMED

AMIGF

AMRC

AMWD

ANCUF

ANSLY

ANSS

AOMFF

AOMOY

APAM

APPF

ARBV

ARES

ASAZF

ASAZY

ASHTY

ASPN

ASYS

ATCMF

ATLC

ATRC

ATVI

ATZAF

AUDC

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BAESY

BANF

BASI

BATRA

BCPC

BCUCY

BEVFF

BF-A

BF-B

BHOOY

BIOS

BKRKY

BLDP

BLSP

BMDPY

BORT

BPOP

BRK-A

BRK-B

Stocks That Hit 52-Week Highs On Friday

Camurus AB

Small Cap

Press Releases

New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl

Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients

CAMRF

CAMX

Camurus

Comments

Camurus

Camurus (OTC:CAMRF) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell